Chemoprevention research: implications for primary care practice

Area of Science:

• Oncology
• Preventive Medicine
• Clinical Research

Background:

• Cancer prevention research is expanding, with significant opportunities for impact.
• Identifying effective agents to reduce cancer incidence in high-risk populations is a key focus.
• Primary care providers (PCPs) are vital collaborators due to their patient access and commitment to prevention.

Purpose of the Study:

• To highlight the advancements in cancer prevention research.
• To inform about the role of PCPs in chemoprevention trials.
• To provide information on current breast and prostate cancer chemoprevention trials and recruitment.

Main Methods:

• Overview of the current landscape of cancer prevention research.
• Discussion on the development and structure of chemoprevention trials.
• Emphasis on the integration of primary care into national research efforts.

Main Results:

• Chemoprevention research is identifying agents that significantly reduce cancer incidence.
• National trials for breast and prostate cancer chemoprevention are actively seeking PCP involvement.
• PCPs offer unique advantages for patient recruitment and long-term follow-up.

Conclusions:

• Cancer prevention research offers significant opportunities for reducing disease burden.
• Primary care settings are essential for the success of large-scale chemoprevention trials.
• Further information and engagement with PCPs are needed to advance these research efforts.